Predictors of coronary artery visualization in Kawasaki disease

Journal of the American Society of Echocardiography

Volumn 24, Issue 1, 2011, Pages 53-59

  Margossian, Renee ^a   Lu, Minmin ^b   Luann Minich, L ^c   Bradley, Timothy J ^d   Cohen, Meryl S ^e   Li, Jennifer S ^f   Printz, Beth F ^g   Shirali, Girish S ^h   Sleeper, Lynn A ^b   Newburger, Jane W ^a   Colan, Steven D ^a  

^a BOSTON CHILDREN S HOSPITAL   (United States)

^b NEW ENGLAND RESEARCH INSTITUTES   (United States)

^c UNIVERSITY OF UTAH   (United States)

^d HOSPITAL FOR SICK CHILDREN   (Canada)

^e CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

^f DUKE UNIVERSITY MEDICAL CENTER   (United States)

^g Och Spine at New York Presbyterian Hospitals   (United States)

^h MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

Core laboratory; Coronary artery; Kawasaki disease; Pediatric; Sedation

Indexed keywords

ACETYLSALICYLIC ACID; IMMUNOGLOBULIN; METHYLPREDNISOLONE;

ARTICLE; CLINICAL ASSESSMENT; CORONARY ARTERY; ECHOCARDIOGRAPHY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MUCOCUTANEOUS LYMPH NODE SYNDROME; PREDICTOR VARIABLE; SINGLE DRUG DOSE;

CHILD, PRESCHOOL; COMORBIDITY; CORONARY ARTERY DISEASE; CORONARY VESSELS; ECHOCARDIOGRAPHY; FEMALE; HUMANS; INCIDENCE; MALE; MUCOCUTANEOUS LYMPH NODE SYNDROME; REPRODUCIBILITY OF RESULTS; RISK ASSESSMENT; RISK FACTORS; SENSITIVITY AND SPECIFICITY; UNITED STATES;

EID: 78650471026     PISSN: 08947317     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.echo.2010.10.015     Document Type: Article

References (20)

1. J.W. Newburger, M. Takahashi, M.A. Gerber, M.H. Gewitz, L.Y. Tani, and J.C. Burns Diagnosis, treatment, and long-term management of Kawasaki disease: a statement for health professionals from the Committee on Rheumatic Fever, Endocarditis and Kawasaki Disease, Council on Cardiovascular Disease in the Young, American Heart Association Circulation 110 2004 2747 2771 (Pubitemid 39453026)
2. S. Naoe, K. Takahashi, H. Masuda, and N. Tanaka Kawasaki disease. With particular emphasis on arterial lesions Acta Pathologica Japonica 41 1991 785 797
3. H. Kato, T. Sugimura, T. Akagi, N. Sato, K. Hashino, and Y. Maeno Long-term consequences of Kawasaki disease. A 10- to 21-year follow-up study of 594 patients Circulation 94 1996 1379 1385
4. K. Durongpisitkul, V.J. Gururaj, J.M. Park, and C.F. Martin The prevention of coronary artery aneurysm in Kawasaki disease: a meta-analysis on the efficacy of aspirin and immunoglobulin treatment Pediatrics 96 1995 1057 1061
5. J.W. Newburger, M. Takahashi, J.C. Burns, A.S. Beiser, K.J. Chung, and C.E. Duffy The treatment of Kawasaki syndrome with intravenous gamma globulin N Engl J Med 315 1986 341 347
6. S. Mavrogeni, G. Papadopoulos, E. Karanasios, and D.V. Cokkinos How to image Kawasaki disease: a validation of different imaging techniques Int J Cardiol 124 2008 27 31
7. T.E. Capannari, S.R. Daniels, R.A. Meyer, D.C. Schwartz, and S. Kaplan Sensitivity, specificity and predictive value of two-dimensional echocardiography in detecting coronary artery aneurysms in patients with Kawasaki disease J Am Coll Cardiol 7 1986 355 360
8. S. Hiraishi, H. Misawa, N. Takeda, Y. Horiguchi, N. Fujino, and N. Ogawa Transthoracic ultrasonic visualisation of coronary aneurysm, stenosis, and occlusion in Kawasaki disease Heart 83 2000 400 405
9. J.W. Newburger, L.A. Sleeper, B.W. McCrindle, L.L. Minich, W. Gersony, and V.L. Vetter Randomized trial of pulsed corticosteroid therapy for primary treatment of Kawasaki disease N Engl J Med 356 2007 663 675
10. B.W. McCrindle, J.S. Li, L.L. Minich, S.D. Colan, A.M. Atz, and M. Takahashi Coronary artery involvement in children with Kawasaki disease: risk factors from analysis of serial normalized measurements Circulation 116 2007 174 179
11. L.H. Baur, J.J. Schipperheyn, E.A. van der Velde, E.E. van der Wall, J.H. Reiber, and R.J. van der Geest Reproducibility of left ventricular size, shape and mass with echocardiography, magnetic resonance imaging and radionuclide angiography in patients with anterior wall infarction. A plea for core laboratories Int J Card Imaging 12 1996 233 240
12. T. Hole, J.E. Otterstad, M. St. John Sutton, G. Froland, I. Holme, and T. Skjaerpe Differences between echocardiographic measurements of left ventricular dimensions and function by local investigators and a core laboratory in a 2-year follow-up study of patients with an acute myocardial infarction Eur J Echocardiogr 3 2002 263 270
13. M. Wong, L. Staszewsky, A. Volpi, R. Latini, S. Barlera, and C. Hoglund Quality assessment and quality control of echocardiographic performance in a large multicenter international study: Valsartan in heart failure trial (Val-HeFT) J Am Soc Echocardiogr 15 2002 293 301
14. S.E. Lipshultz, K.A. Easley, E.J. Orav, S. Kaplan, T.J. Starc, and J.T. Bricker Reliability of multicenter pediatric echocardiographic measurements of left ventricular structure and function: the prospective P(2)C(2) HIV study Circulation 104 2001 310 316
15. E.S. Chung, A.R. Leon, L. Tavazzi, J.P. Sun, P. Nihoyannopoulos, and J. Merlino Results of the Predictors of Response to CRT (PROSPECT) trial Circulation 117 2008 2608 2616
16. T.H. Marwick Hype and hope in the use of echocardiography for selection for cardiac resynchronization therapy: the Tower of Babel revisited Circulation 117 2008 2573 2576
17. L.C. Heistein, C. Ramaciotti, W.A. Scott, M. Coursey, P.W. Sheeran, and M.S. Lemler Chloral hydrate sedation for pediatric echocardiography: physiologic responses, adverse events, and risk factors Pediatrics 117 2006 e434 e441
18. S. Coskun, H. Yuksel, and A. Onag Chloralhydrate in children undergoing echocardiography Indian J Pediatr 68 2001 319 322
19. M. Lipshitz, B.L. Marino, and S.T. Sanders Chloral hydrate side effects in young children: causes and management Heart Lung 22 1993 408 414
20. K.L. Napoli, C.G. Ingall, and G.R. Martin Safety and efficacy of chloral hydrate sedation in children undergoing echocardiography J Pediatr 129 1996 287 291